Healthcare | March 24, 2022
HaystackAnalytics sees alarming rise in TB cases
A staggering 65% of the TB cases in India are in the 15-45 age group
A staggering 65% of the TB cases in India are in the 15-45 age group
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
The FDA decision is primarily informed by the positive results of a proof-of-concept, Phase 2a study evaluating the safety, immunogenicity, and efficacy of a single dose of 120µg RSVpreF in a human viral challenge model in healthy adults 18 to 50 years of age
The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices
This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The product will be manufactured at Lupin’s facility in Goa, India
Subscribe To Our Newsletter & Stay Updated
